Skip to main content
Caplight Logo









OriGene Technologies

OriGene Technologies

Private
Rockville, MarylandHealthcare & Life Scienceshttps://www.origene.com/

Last Round

Private Equity

May 4, 2020

Total Funding Raised

$37.3M

Company Overview

OriGene Technologies is a biotechnology company that develops, manufactures, and sells genome-wide research and diagnostic products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

cDNA cloneslife science reagentsantibodiesrecombinant proteinsreagent supplierCRISPR gene editingdrug discovery toolsviral vectorsELISA kitscustom gene synthesiscustom protein productioncustom antibody developmentCRO servicesRNAiqPCR arrays

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OriGene Technologies Comparables

Compare OriGene Technologies with similar companies based on industry and business-model similarity.

OriGene Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GeneCopoeia, Inc.
84%
Sino Biological Inc.
81%
Abcam
79%

OriGene Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMay 4, 2020
Series CMar 21, 2013
Series BMar 17, 2010

Key People

Founding team and executive leadership

Tracy Xie

CEO and CFO

Executive Team

OriGene Technologies Investors

Notable investors and investment history

OriGene Technologies investors
InvestorRounds
Cathay CapitalPrivate Equity
IDG CapitalPrivate Equity, Series C, Series B
Kleiner Perkins ChinaSeries C
Morningside VenturesSeries B, Series A
Zero2IPO GroupSeries B
Qiming Venture PartnersSeries C
Mérieux Equity PartnersPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors grew 31% MoM to 121.4K.

  • Mar 9, 2025

    Monthly visitors increased 31% MoM, reaching 92.4K.

OriGene Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OriGene Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OriGene Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersRockville, Maryland
Employee Range128
Year Founded1996
Last FundingMay 4, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?